BioAge Labs, Inc. financial data

Symbol
BIOA on Nasdaq
Location
1445 A South 50 Th Street, Richmond, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.29K %
Debt-to-equity 9.99 %
Return On Equity -25.1 % -121%
Return On Assets -22.8 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.9M shares +0.02%
Common Stock, Shares, Outstanding 35.9M shares +4.83%
Entity Public Float 474M USD
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 35.9M shares +926%
Weighted Average Number of Shares Outstanding, Diluted 35.9M shares +926%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.05M USD
Research and Development Expense 68.7M USD -7.52%
General and Administrative Expense 26.9M USD +41.2%
Operating Income (Loss) -89.7M USD +6.51%
Nonoperating Income (Expense) 13.9M USD +121%
Net Income (Loss) Attributable to Parent -75.8M USD -6.84%
Earnings Per Share, Basic 14 USD/shares +91.6%
Earnings Per Share, Diluted 14 USD/shares +91.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 216M USD -35.5%
Marketable Securities, Current 70.2M USD
Accounts Receivable, after Allowance for Credit Loss, Current 515K USD
Assets, Current 291M USD -13.6%
Property, Plant and Equipment, Net 973K USD +79.2%
Operating Lease, Right-of-Use Asset 2.88M USD +964%
Other Assets, Noncurrent 227K USD
Assets 305M USD -9.57%
Accounts Payable, Current 5.02M USD +139%
Employee-related Liabilities, Current 3.16M USD +6.51%
Contract with Customer, Liability, Current 7.51M USD
Liabilities, Current 24.5M USD +28.4%
Contract with Customer, Liability, Noncurrent 556K USD
Operating Lease, Liability, Noncurrent 2.43M USD
Liabilities 27.6M USD +16.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 275K USD +152%
Retained Earnings (Accumulated Deficit) -307M USD -32.7%
Stockholders' Equity Attributable to Parent 277M USD -11.6%
Liabilities and Equity 305M USD -9.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.4M USD -10.8%
Net Cash Provided by (Used in) Financing Activities -1.5M USD -101%
Net Cash Provided by (Used in) Investing Activities -78M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 35.9M shares +4.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -96.9M USD -164%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 257M USD +45.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 217K USD -49.2%
Deferred Tax Assets, Valuation Allowance 56.1M USD +43.7%
Deferred Tax Assets, Gross 56.1M USD +43.6%
Operating Lease, Liability 3.01M USD
Payments to Acquire Property, Plant, and Equipment 426K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75.7M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid 4.13M USD
Property, Plant and Equipment, Gross 1.39M USD +28%
Operating Lease, Liability, Current 580K USD +112%
Lessee, Operating Lease, Liability, to be Paid, Year Two 763K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 617K USD +209%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.12M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 786K USD
Deferred Tax Assets, Operating Loss Carryforwards 22.8M USD +23.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 810K USD
Operating Lease, Payments 100K USD 0%
Additional Paid in Capital 585M USD +7.21%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 60K USD +17.6%
Share-based Payment Arrangement, Expense 11.7M USD +51%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%